Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.

Cancer research - 1 Apr 1998

Falette N, Paperin M P, Treilleux I, Gratadour A C, Peloux N, Mignotte H, Tooke N, Löfman E, Inganäs M, Bremond A, Ozturk M, Puisieux A

Abstract excerpt

The most important subgroup of breast cancer patients for which reliable prognostic factors are needed are women without axillary lymph node involvement. Although overall, these patients have a good prognosis, it is known that 20-30% will experience a recurrence of the disease. To determine the p...

Topics

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Breast Neoplasms
Female
Follow-Up Studies
Genes, p53
Humans
Immunohistochemistry
Lymph Nodes
Middle Aged
Mutation
Prognosis
Survival Analysis
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 9537247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9537247-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics